⌘K
Loading ticker…
UroGen Pharma Ltd. Ordinary Shares · Healthcare · Pharmaceutical Products
As of 2026-06-26, UroGen Pharma Ltd. Ordinary Shares (URGN) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 78. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 2.12×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating A
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
URGN is in a stage 2 uptrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 22.6% / 53.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
URGN is held by 2 ETFs as of Feb 2026. Top owner: VHT at 0.01% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Feb 2026.
| ETF | Weight | Value |
|---|---|---|
| VHTVanguard Health Care ETF | 0.01% | $3M |
| VTHRVanguard Russell 3000 ETF | 0.00% | $63K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | URGN Jan avg: 2.23% median: 4.02% win: 75% σ: 13.80% n: 4 2022-04-12 → 2026-05-29 | URGN Feb avg: 3.12% median: 4.90% win: 50% σ: 13.59% n: 4 2022-04-12 → 2026-05-29 | URGN Mar avg: -7.17% median: -13.72% win: 25% σ: 16.43% n: 4 2022-04-12 → 2026-05-29 | URGN Apr avg: 8.94% median: 5.24% win: 60% σ: 19.42% n: 5 2022-04-12 → 2026-05-29 | URGN May avg: -17.70% median: -14.58% win: 20% σ: 30.14% n: 5 2022-04-12 → 2026-05-29 | URGN Jun avg: 76.94% median: 40.06% win: 100% σ: 99.52% n: 4 2022-04-12 → 2026-05-29 (current) | URGN Jul avg: 35.54% median: 18.58% win: 50% σ: 53.05% n: 4 2022-04-12 → 2026-05-29 | URGN Aug avg: -9.42% median: -10.21% win: 25% σ: 9.75% n: 4 2022-04-12 → 2026-05-29 | URGN Sep avg: -3.57% median: -3.06% win: 50% σ: 13.68% n: 4 2022-04-12 → 2026-05-29 | URGN Oct avg: 5.40% median: -0.43% win: 50% σ: 26.47% n: 4 2022-04-12 → 2026-05-29 | URGN Nov avg: 8.58% median: 10.63% win: 75% σ: 28.62% n: 4 2022-04-12 → 2026-05-29 | URGN Dec avg: -4.41% median: -6.32% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-05-29 |